HIV-1 tat interaction with RNA polymerase IIC-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter

被引:79
作者
Deng, LW
Ammosova, T
Pumfery, A
Kashanchi, F
Nekhai, S
机构
[1] Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA
[2] Howard Univ, Dept Biochem, Washington, DC 20059 USA
[3] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA
关键词
D O I
10.1074/jbc.M111349200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human immunodeficiency virus, type I (HIV-1), Tat protein activates viral gene expression through promoting transcriptional elongation by RNA polymerase II (RNAPII). In this process Tat enhances phosphorylation of the C-terminal domain (CTD) of RNAPII by activating cell cycle-dependent kinases (CDKs) associated with general transcription factors of the promoter complex, specifically CDK7 and CDK9. We reported a Tat-associated T-cell-derived kinase, which contained CDK2. Here, we provide further evidence that CDK2 is involved in Tat-mediated CTD phosphorylation and in HIV-1 transcription in vitro. Tat-mediated CTD phosphorylation by CDK2 required cysteine 22 in the activation domain of Tat and amino acids 42-72 of Tat. CDK2 phosphorylated Tat itself, apparently by forming dynamic contacts with amino acids 15-24 and 36-49 of Tat. Also, amino acids 24-36 and 45-72 of Tat interacted with CTD. CDK2 associated with RNAPII and was found in elongation complexes assembled on HIV-1 long-terminal repeat template. Recombinant CDK2/cyclin E stimulated Tat-dependent HIV-1 transcription in reconstituted transcription assay. Immunodepletion of CDK2/cyclin E in HeLa nuclear extract blocked Tat-dependent transcription. We suggest that CDK2 is part of a transcription complex that is required for Tat-dependent transcription and that interaction of Tat with CTD and a dynamic association of Tat with CDK2/cyclin E stimulated CTD phosphorylation by CDK2.
引用
收藏
页码:33922 / 33929
页数:8
相关论文
共 34 条
[1]   PURIFICATION AND CHARACTERIZATION OF THE DNA-BINDING PROTEIN NER OF BACTERIOPHAGE MU [J].
ALLET, B ;
PAYTON, M ;
MATTALIANO, RJ ;
GRONENBORN, AM ;
CLORE, GM ;
WINGFIELD, PT .
GENE, 1988, 65 (02) :259-268
[2]   Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat [J].
Bieniasz, PD ;
Grdina, TA ;
Bogerd, HP ;
Cullen, BR .
EMBO JOURNAL, 1998, 17 (23) :7056-7065
[3]   Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain [J].
Cho, EJ ;
Kobor, MS ;
Kim, M ;
Greenblatt, J ;
Buratowski, S .
GENES & DEVELOPMENT, 2001, 15 (24) :3319-3329
[4]   Loss of G1/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1 [J].
Clark, E ;
Santiago, F ;
Deng, LW ;
Chong, SY ;
de la Fuente, C ;
Wang, L ;
Fu, P ;
Stein, D ;
Denny, T ;
Lanka, V ;
Mozafari, F ;
Okamoto, T ;
Kashanchi, F .
JOURNAL OF VIROLOGY, 2000, 74 (11) :5040-5052
[5]   The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II [J].
Cujec, TP ;
Okamoto, H ;
Fujinaga, K ;
Meyer, J ;
Chamberlin, H ;
Morgan, DO ;
Peterlin, BM .
GENES & DEVELOPMENT, 1997, 11 (20) :2645-2657
[6]   Reversible phosphorylation of the C-terminal domain of RNA polymerase II [J].
Dahmus, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19009-19012
[7]   CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 Tat-P-TEFb complex to TAR RNA [J].
Garber, ME ;
Mayall, TP ;
Suess, EM ;
Meisenhelder, J ;
Thompson, NE ;
Jones, KA .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (18) :6958-6969
[8]   Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription [J].
GarciaMartinez, LF ;
Mavankal, G ;
Neveu, JM ;
Lane, WS ;
Ivanov, D ;
Gaynor, RB .
EMBO JOURNAL, 1997, 16 (10) :2836-2850
[10]  
Huet J, 1996, METHOD ENZYMOL, V273, P249